The univariate analysis revealed that the overall survival outcome of patients with dMMR GC is related to family history, vascular tumor thrombus, clinical stage, number of lymph node metastases, and strong HER2 expression. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.